Skip to content
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Menu
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Happy News

A New Era in Pain Relief

In a historic leap for medicine, the FDA has approved the first-ever non-opioid drug for treating moderate to severe acute pain. Called suzetrigine and sold under the name Journavx, this groundbreaking medication offers powerful pain relief without the risks of addiction or dependency that come with traditional opioids. Developed by Vertex Pharmaceuticals, it works by targeting NaV1.8 pain signals in the peripheral nervous system, avoiding the central nervous system entirely.

This targeted approach allows Journavx to match the pain-fighting power of opioids for short-term issues like surgery recovery or trauma—without the side effects or long-term dangers. For millions of patients and physicians seeking safer alternatives, this marks the beginning of a new chapter in pain management. With fewer risks and equal effectiveness, this approval may change how pain is treated in hospitals and clinics around the world.

PrevPreviousScientists Reprogram Cells to Reverse This Disease
NextThis Adorable Species Thrives After Returning to the WildNext

Recent Articles

Happy News

A Runner Broke The Two-Hour Barrier For The First Time Ever

April 27, 2026

Something happened today at the TCS London Marathon that the running world has been chasing for decades. Kenyan runner Sabastian Sawe crossed the finish line in 1:59:30 — making him the first person in history to run a marathon in under two hours under official, record-eligible conditions. That is not

Read More
Happy News

6500 Volunteers Just Built 10000 Beds In A Day For Kids Who Have Never Had One

April 27, 2026

More than 140,000 children across the United States do not have a bed to sleep in, and this week a group of 6,500 volunteers decided to make a serious dent in that number, gathering at the Charlotte Convention Center in North Carolina and building over 10,000 beds in just 24

Read More
Happy News

The FDA Just Approved The First Gene Therapy For Inherited Deafness And The Company Is Making It Free

April 27, 2026

The Food and Drug Administration has approved the first ever gene therapy for inherited hearing loss, a one-time treatment developed by Regeneron Pharmaceuticals that has proven life-changing for children born deaf due to a mutation in a gene called OTOF, which the ear needs to transmit sound signals to the

Read More
« Previous Next »
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
Copyright © 2026 HappyNews.